Successful Treatment of Disseminated Subcutaneous Panniculitis-Like T-Cell Lymphoma with Single Agent Oral Cyclosporine as a First Line Therapy

Subcutaneous panniculitis-like T-cell lymphoma (SPTL) is a rare cutaneous neoplasm of mature cytotoxic T-cells. Currently there are no standardized therapies for SPTL; however good responses have been seen with chemotherapy regimens generally employed for B-cell lymphomas. Cyclosporine, an immunosup...

Full description

Saved in:
Bibliographic Details
Main Authors: Nida Iqbal, Vinod Raina
Format: Article
Language:English
Published: Wiley 2014-01-01
Series:Case Reports in Dermatological Medicine
Online Access:http://dx.doi.org/10.1155/2014/201836
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832549145736380416
author Nida Iqbal
Vinod Raina
author_facet Nida Iqbal
Vinod Raina
author_sort Nida Iqbal
collection DOAJ
description Subcutaneous panniculitis-like T-cell lymphoma (SPTL) is a rare cutaneous neoplasm of mature cytotoxic T-cells. Currently there are no standardized therapies for SPTL; however good responses have been seen with chemotherapy regimens generally employed for B-cell lymphomas. Cyclosporine, an immunosuppressant, has shown good responses in relapsed/refractory SPTL; however its use in first line setting is not well established. We, herein, describe a 22-year-old girl with disseminated SPTL who attained complete clinical remission with single agent oral cyclosporine used as a first line therapy.
format Article
id doaj-art-167c3a8cdeec4013978fb7b9cfce1c3a
institution Kabale University
issn 2090-6463
2090-6471
language English
publishDate 2014-01-01
publisher Wiley
record_format Article
series Case Reports in Dermatological Medicine
spelling doaj-art-167c3a8cdeec4013978fb7b9cfce1c3a2025-02-03T06:12:07ZengWileyCase Reports in Dermatological Medicine2090-64632090-64712014-01-01201410.1155/2014/201836201836Successful Treatment of Disseminated Subcutaneous Panniculitis-Like T-Cell Lymphoma with Single Agent Oral Cyclosporine as a First Line TherapyNida Iqbal0Vinod Raina1Department of Medical Oncology, Dr. B. R. A. Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi 110029, IndiaDepartment of Medical Oncology, Dr. B. R. A. Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi 110029, IndiaSubcutaneous panniculitis-like T-cell lymphoma (SPTL) is a rare cutaneous neoplasm of mature cytotoxic T-cells. Currently there are no standardized therapies for SPTL; however good responses have been seen with chemotherapy regimens generally employed for B-cell lymphomas. Cyclosporine, an immunosuppressant, has shown good responses in relapsed/refractory SPTL; however its use in first line setting is not well established. We, herein, describe a 22-year-old girl with disseminated SPTL who attained complete clinical remission with single agent oral cyclosporine used as a first line therapy.http://dx.doi.org/10.1155/2014/201836
spellingShingle Nida Iqbal
Vinod Raina
Successful Treatment of Disseminated Subcutaneous Panniculitis-Like T-Cell Lymphoma with Single Agent Oral Cyclosporine as a First Line Therapy
Case Reports in Dermatological Medicine
title Successful Treatment of Disseminated Subcutaneous Panniculitis-Like T-Cell Lymphoma with Single Agent Oral Cyclosporine as a First Line Therapy
title_full Successful Treatment of Disseminated Subcutaneous Panniculitis-Like T-Cell Lymphoma with Single Agent Oral Cyclosporine as a First Line Therapy
title_fullStr Successful Treatment of Disseminated Subcutaneous Panniculitis-Like T-Cell Lymphoma with Single Agent Oral Cyclosporine as a First Line Therapy
title_full_unstemmed Successful Treatment of Disseminated Subcutaneous Panniculitis-Like T-Cell Lymphoma with Single Agent Oral Cyclosporine as a First Line Therapy
title_short Successful Treatment of Disseminated Subcutaneous Panniculitis-Like T-Cell Lymphoma with Single Agent Oral Cyclosporine as a First Line Therapy
title_sort successful treatment of disseminated subcutaneous panniculitis like t cell lymphoma with single agent oral cyclosporine as a first line therapy
url http://dx.doi.org/10.1155/2014/201836
work_keys_str_mv AT nidaiqbal successfultreatmentofdisseminatedsubcutaneouspanniculitisliketcelllymphomawithsingleagentoralcyclosporineasafirstlinetherapy
AT vinodraina successfultreatmentofdisseminatedsubcutaneouspanniculitisliketcelllymphomawithsingleagentoralcyclosporineasafirstlinetherapy